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Aluminum action on mouse bone cell metabolism and response to PTH
and 1,25(OH)2D3. Aluminum (Al) accumulation in bone is associated
with low bone formation and mineralization rates; resorption may also
be reduced. The mechanism of these Al-induced changes was investi-
gated using cultured mouse osteoblast—like (OB) and osteoclast—like
(OC) cells. The Al effect on bone resorption was measured by the in
vitro release of 45Ca and /3-glucuronidase from mouse fetal limb—bones.
Al had a biphasic effect. High concentrations (>1.5 x 106 M) of Al
inhibited collagen and DNA synthesis, ornithine decarboxylase and
alkaline phosphatase activity in OB, and depressed tartrate-resistant
acid phosphatase activity in OC. Lower Al concentrations stimulated
these cellular activities and 45Ca and /3-glucuronidase release from fetal
bones. Al had no effect on basal cAMP levels in OB but inhibited the
stimulating effect of bPTH on cAMP content. Al also altered the
I ,25(OH)D1 effects on the ornithine decarboxylase activity of OB cells.
These data suggest that: (i) the low bone formation observed in vivo
during Al intoxication may be due to the inhibition of collagen synthesis
and to depressed cell proliferation; and (ii) Al may indirectly influence
bone remodeling by interfering with the actions of bPTH and
l,25(OH)2D3 on bone cells.
Aluminum (Al) accumulation is an important toxic factor in
patients with renal failure [1]. The main sources of Al are
phosphate binders and/or Al-contaminated dialysate solutions
[2—5].
Skeletal accumulation of Al induces vitamin D-resistant
osteomalacia, a disorder characterized by reduced numbers of
osteoblasts and osteoclasts associated with normal or low
plasma, alkaline phosphatase activity and relative parathyroid
hormone (PTH) deficiency [5, 61. The mechanism by which Al
induces these bone lesions is not fully understood. Several
studies have shown that Al may be toxic to osteoblasts [7—9]
and that the abnormal function of these cells may be responsible
for the reduced bone—matrix formation and mineralization.
Concerning bone resorption, aluminum intoxicated osteomala-
cic patients do not usually have histologic evidence of osteitis
fibrosa. This could be secondary to an inhibition of PTH release
by Al which has been shown to occur in severely Al-intoxicated
patients [101 and in parathyroid cells or slices incubated in vitro
with high doses of Al [II, 12]. However, the possibility of a
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direct Al effect on the sensitivity of osteoclasts to PTH cannot
be excluded.
We have recently shown that, in organ culture, Al interferes
directly not only with the synthesis of bone alkaline phospha-
tase, which reflects osteoblast activity, but also with the syn-
thesis of acid phosphatase, which is abundant in osteoclasts
[13]. In the present study we tested the effect of Al on
osteoblast function by measuring alkaline phosphatase activity,
ornithine decarboxylase activity, DNA and collagen synthesis
in cultured osteoblast—like cells derived from neonatal mouse
parietal—bones. We also investigated a possible direct effect of
Al on bone resorption using tartrate—resistant acid phosphatase
activity in cultured osteoclast—like cells and 45Ca and /3
glucuronidase release from fetal mouse limb—bones as indica-
tions of osteoclastic function. Finally, we explored the possi-
bility of an interaction between Al and bPTH or I ,25-(OH)2D3
influencing bone cell activities.
Methods
Cell isolation and culture
Parietal bones without sutures were aseptically removed
from neonatal mouse calvaria, care being taken not to damage
the periosteum. The dissected bones were then transferred to a
sterile 25 ml Erlenmeyer flask, containing solution A (137 mM
NaCI, 2.7 mtt KCI, 3 mM NaH2PO4) plus 4 mrs EDTA, pH 7.2.
After a five minute digestion, the solution was removed and
fresh solution A plus EDTA was added for 20 minutes. The
released cells constituted the osteoclast—like (OC) cell popula-
tion. Solution A containing 180 U/mI crude collagenase (CLS
type I) was added to the remaining bones. After four sequential
20 minute digestions, the cells obtained from the last three
digestions were pooled and constituted the osteoblast—like (OB)
population. Aliquots from both OB and OC populations were
counted in a hemocytometer. Cells were seeded in multiwell
plates (Costar cluster 12) and cultured at 37°C in an atmosphere
of 95% air/5% CO2 until confluent. OC were seeded at a density
of 20 x l0 per cm2 in 2 ml of a-MEM medium containing 2%
fetal calf serum (FCS). OB were seeded at a density of 10 x l0
per cm2 in 2 ml of modified Ca2-free BGJ (m BGJ) medium
supplemented with 10% FCS, cultured in this medium for 24
hours, and then in BGJ medium with I mM Ca and 10% FCS.
The media were renewed every 48 hours.
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Cyclic AMP assay
Cells were incubated for 5, 15, 30 and 120 mintues in Hanks'
balanced salt solution containing 25 mrvi HEPES, 0.05% bovine
serum albumin (BSA), I mi Ca, 0.2 mi isobutyl methyixan-
thine (IBMX), and the substances to be tested or their vehicle.
Cells were then extracted by sonication in the presence of 90%
propanol. cAMP was measured by the protein binding assay of
Lust et al [14] and expressed as pmoles per g DNA [15].
Alkaline and acid phosphatase assays
Cells were pre-incubated for 16 to 18 hours in serum—free
medium before being placed in serum—free medium containing
the substance to be tested or its solvent for 24 hours. Following
incubation, the cells were washed three times with 0.25 M
sucrose, removed from the dish with a rubber policeman,
resuspended in 0.25 M sucrose, 0.1% Triton X100 and 0.3 M KCI
and disrupted by sonication (2 x 20 sec at 40 KHz). Particulate
matter was removed by centrifugation at 600 xg for 10 minutes
and the supernatants were stored frozen until used for enzyme
assays. The incubation solutions for acid phosphatase con-
tained 100 m acetate buffer, pH 5, 5 mii ascorbic acid, 0.1%
Triton X100, 10 m sodium tartrate and 8 mM p-nitrophenyl-
phosphate. The incubation solutions for alkaline phosphatase
contained 100 mst triethanolamine buffer pH 9.8, 25 msi MgCl2
and 15 msi p-nitrophenylphosphate. Incubations at 37°C were
stopped after 30 minutes by the addition of 1.5 ml of 100 mM
NaOH plus 10 mri EDTA to prevent precipitation of divalent
metal ions. Acid or alkaline phosphatase was assayed by
measuring the absorbance of the liberated p-nitrophenol at 405
nm. All reactions were linear with respect to the amount of
enzyme and the incubation time.
Activities are expressed as nanomole of substrate liberated
per minute per g of DNA.
Tartrate—resistant acid phosphatase activity was measured in
cell extracts and in culture media. Alkaline phosphatase activity
(ALP) was only measured in cytoplasmic extracts because of
the low level found in media (5 2 nmol/min/pg DNA).
Collagen analysis
Cells were cultured for 24 hours in modified BGJ medium
(mBGJ) containing 1 m Ca, 3 m phosphate, 1 mM proline,
100 ig/ml ascorbic acid and 0.05 mg/mI BSA. They were then
incubated for 24 hours in fresh medium containing the appro-
priate test substance. Five Ci 2,3-3H proline (SA:30 Ci/m-
mole) were added to the medium for the final four hours of the
incubation period. The cells were washed five times with
phosphate—buffered saline, pH 7.4 at 4°C, to terminate incuba-
tion, scraped off and homogenized in 0.5 M acetic acid using an
all—glass homogenizer. The incorporation of 3H proline into
collagenase—digestible (CDP) and non-collagen (NCP) proteins
was determined using purified bacterial collagenase according
to the method of Peterkofsky and Dielgelmann [16]. Blanks
without enzyme were included for each sample; counting
efficiencies were determined by internal standardization. The
relative rate of collagen synthesis was corrected for the relative
abundance of proline residues in collagen compared to non-
collagen protein [17].
An aliquot of the homogenate was treated with 100 g/ml of
pepsin for 15 hours at 5°C to analyze the types of synthesized
collagen. The pepsin digest was brought to pH 8 with NaOH
and submitted to salt precipitations using 15 and 5% NaCI.
Collagen types were separated by SDS-PAGE on slab gels
according to the method of Laemmli [18]. Reduction of disulfide
bonds were carried out on some samples [19].
Ornithine—decarboxylase assay
Osteoblasts were inoculated at a density of 10 x l0 cells/cm2
in 25-T flasks with silicon stoppers and cultured until conflu-
ency in mBGJ medium supplemented with 10% FCS. Activa-
tion of ODC was achieved by a 16 to 18 hour serum starvation
in medium minus serum followed by replacement with mBGJ
medium without FCS and supplemented with the substances to
be tested. Enzyme assay was done in situ by the method of
Patterson and Maxwell [20]. Assay mixtures contained 0.2 ml of
0.5 mi pyridoxal 5' phosphate (PLP), 0.2 ml of 25 mM
dithiothreitol (DTT), 0.4 ml of L-('4C)ornithine prepared by
mixing the isotope with I m carrier ornithine to give 250 to 300
dpm/nmol and 1.2 ml of Tris-HCI buffer, pH 7.1. For reagent
controls, PLP was replaced by 0.2 ml of 50 mrvt semicarbazide
and DTT by 0.2 ml of 1 mrvt p-chloromercuriphenylsuifonic
acid. All reactions were linear with respect to the number of
cells assayed and the incubation time. ODC activity is ex-
pressed as nmoie of CO2 per mg of protein per hour. Proteins
were assayed by Bradford's method [21].
Measurement of DNA content
Total DNA was measured according to the method of
Karsten and Wollenberger [15] using ethidium bromide for the
direct fluorometric estimation of DNA.
Bone resorption
The forelimb—rudiment method of Raisz and Niemann [22]
was employed. Seventeen—day pregnant mice were injected
with 200 pCi of 45Ca (SA 22 Ci/g) and, 24 hours later, the
18-day—old fetuses were removed and the radii and ulnae of the
fetuses dissected out. Forelimb rudiments were precultured in
mBGJ medium for 24 hours. They were then transferred to
mBGJ medium supplemented with 0.1 mg/mi BSA and cultured
in the presence or absence of Al. 45Ca and f3-glucuronidase
activity were measured in media and bones after 48 hours in
culture. /3 glucuronidase was assayed by measuring the hydrol-
ysis of phenolphthaleine giucuronidate in 0.1 Macetate buffer,
pH 4.5. Bones were homogenized with an all—glass homoge-
nizer in 0.1% Triton X100. Aliquots were taken for enzyme
assay and the remainder was extracted with 0.5 M EDTA for
two hours at 37°C for 45Ca analysis. Values are presented as
percentage of total 45Ca or /3-giucuronidase activity released
into the medium.
Test substances
The water used for the preparation of Al solutions and mBGJ
or aMEM medium was purified using a Milli-Q Millipore
(Bethesda, Maryland, USA) water system and contained no
detectable traces of Al.
Aluminum chloride (AICI3, 6 H2O; Sigma Chemical Corpora-
tion, St. Louis, Missouri, USA) dissolved in water was used at
concentrations varying from 10-8 M to 1O M. Aluminum
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Fig. 1. Effects of aluminum on
tartrate—resislant acid phosphatase activity
measured in osteoclast—like cell extracts (A)
and in media of osteoclast—like cells (B).
Values are means SEM of five different
10-6 W5 experiments with four wells for each point.
Values significantly different from control
values, *D < 0.001.
100 F0_L_, I I I
Concentration of aluminum M
Fig. 2. Effects of aluminum on alkaline phosphatase activity measured
in osteoblast—like cells. Values are means SEM of five different
experiments with four wells for each point. Values significantly dif-
ferent from control values, 6P < 0.001; ** < 0.05.
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measurements were performed directly in the various media by
flameless atomic absorption [231. Concentrations found in the
media compared to the theoretical concentrations were: 9.9
/.LM/liter versus 10 LM/liter (10 M); 5.8 tM/liter versus 6
M/1iter (6 x 10—6 M); 2.8 LM/liter versus 3 /LM/liter (3 x l06
M); 1.6 /LM/liter versus 1.5 JiM/liter (1.5 x 106 M); 1 JiM/liter
versus 1 JiM/liter (106 M); 0.09 JiM/liter versus 0.1 JiM/liter
(10 M); and 0.01 JiM/liter versus 0.01 p.M/liter (108 M).
Control media did not contain any detectable trace of Al. These
results represent the mean values of 10 measurements. The
addition of 5 p.1 of Al stock solutions to the medium (2 ml)
neither changed the medium pH nor produced cloudiness in the
medium. The supplementation of the medium with 0.05 mg/mI
BSA did not modify the measured Al concentrations in the
media and the biochemical results obtained with or without
BSA in media containing Al were comparable in amplitude.
1,25-(OH)2D3 was used at a concentration of iO M. The
stock solution of the metabolite was 10 M in ethanol.
bPTH(l-84) was used at a final concentration of l0 M.
All experiments on the test substances were done in the
absence of fetal calf serum. Preliminary results showed that the
addition of ethanol, bPTH solvent, water or ethanol plus bPTH
solvent and water did not modify the results as compared to
untreated cultures.
Radiolabeled products were purchased from Amersham (Les
Ulis, France). Crude CLS type I collagenase and 5275CLS Pa
bacterial collagenase were purchased from Worthington Bio-
chemical Corporation (Freehold, New Jersey, USA). Sources
of other chemicals were: Sigma Chemical Company (St. Louis,
Missouri, USA) for BSA, p-nitrophenyl phosphate, proline,
EDTA, ascorbic acid, TCA, Hepes, calcium chloride, tanic
acid, Trizma buffer and L-ornithine; and PackardBecker BY
Chemical Operations (Groningen, The Netherlands) for scintil-
lation solutions.
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Statistical analysis
First, the SNEDECOR F test was used to determine whether
there was a variation from one experiment to another for each
Al concentration. None was found (P < 0.001). Data were
expressed as the mean standard error of the mean (sEM) for
the total set of figures (N) at each Al concentration. The
statistical significance was determined by Student's i-test for
unpaired data.
Results
Acid and alkaline phosphatases of osteoblast— and
osteoclast—like cells
Tartrate—resistant acid phosphatase activity, which repre-
sents 95% of the total acid phosphatase activity in OC cells, was
stimulated by Al concentrations ranging from 10-8 M to 1.5 x
l06 M, (Fig. 1A). A decrease of the stimulatory action or even
4
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4
A
Aluminum and bone cells 739
bPTH (10- M) induced an inhibition of the CDP labeling under
the same experimental conditions (Fig. 4).
Ornithine—decarboxylase activity in osteoblast—like cells
ODC activity of OB cells was increased in Al concentrations
ranging from 10—8 M to 1.5 x 10—6 M, whereas higher concen-
trations inhibited enzyme activity (Fig. 5). In the absence of
added aluminum, l,25-(OH)2D3 (l0 M) decreased and bPTH
(10 M) increased ODC activity. Addition of I ,25-(OH)2D3 to
the medium of cells treated with Al decreased the stimulating
effect of these low Al doses (Fig. 5) while the inhibitory effects
of I ,25-(OH)2D3 and Al were not additive in cells incubated with
high doses of Al. No cumulative effect was observed when the
cells were treated simultaneously with bPTH and stimulatory
concentrations of Al (Fig. 5). However, high doses of Al
produced a significant decrease in the stimulatory effect of
bPTH (Fig. 5).
Effects of aluminum, 1 ,25-(OH)2D3 and bPTH on
osteoblast—like cell proliferation
Increasing the concentration of Al from 108M to 10_6 M
resulted in a progressive increase in cell proliferation as mea-
sured by DNA synthesis. High doses of Al significantly reduced
(P < 0.001) DNA content. Under the same experimental
conditions, bPTH increased and l,25-(OH)2D3 had no effect on
the DNA content (Table 1).
cAMP content of osteoclast— and osteoblast—like cells
a2 (I)
Fig. 3. SDS polyacrylamide gel electrophoresis. Collagen preparations
were denatured and electrophoresed in 5% polyacrylamide slab gels
using the Laemmli method. A and B indicate unreduced and reduced
samples, respectively.
an inhibitory effect was observed at higher Al concentrations
(Fig. 1A). The release of tartrate—resistant acid phosphatase
into the medium was augmented at low Al concentrations and
remained somewhat above control levels at high (10-6 M) Al
concentrations (Fig. lB).
A dose—dependent biphasic effect of Al was also observed on
the alkaline phosphatase activity of OB cells. High doses of Al
significantly inhibited (P < 0.001) ALP whereas low concentra-
tions (from 1O M to 1.5 x 10-6 M) increased activity (Fig. 2).
Collagen synthesis of osteoblast—like cells
As shown in Figure 3, OB cells synthesized type I collagen.
Al concentrations up to l0- M did not affect 3H proline
incorporation into CDP or NCP (Fig. 4). An increase in the
NCP labeling was observed at concentrations, from 10-6 M to
1.5 x 10-6 M, which induced a relative diminution of the
percentage of collagen synthesized. At higher concentrations,
the 3H proline incorporation into CDP was decreased, indicat-
ing an inhibition of collagen synthesis. Both 1 ,25-(OH)2D3 and
The cAMP content of OC or OB cells was not sensitive to
exposures of 5 to 120 minutes to concentrations of Al from l0-
M to l0- M. In OC it was found to be 1 0.04 pmol/jsg DNA
for controls and from 0.9 0.03 to 1.22 0.09 pmol/sg DNA
in the presence of Al. In the presence of sCT (0.1 U/mI) cAMP
content was increased (7.8 0.09 pmolItg DNA) after five
minutes of incubation. In OB control values (2.1 0.1 pmol4tg
DNA) were comparable to those found in the presence of Al
(2.05 0.06 to 2.4 0.2 pmol/g DNA). Prior incubation with
Al produced a dose-dependent reduction of the cAMP content
of OB cells stimulated by bPTH (Table 2).
Aluminum effects on bone resorption
Al concentrations from 10—8 M to 10—6 M increased the
release of 45Ca and -glucuronidase in 48 hour cultures (Fig. 6).
The effects were much greater for /3-glucuronidase. The total
activity of the enzyme in bone and medium showed a progres-
sive increase with increasing concentrations of Al. The activity
of bone enzyme was inhibited at concentrations above 106 M
and the release into the medium was reduced. High doses of Al
had no effect on 45Ca release (Fig. 6).
Discussion
These results show that Al has a direct effect on the metab-
olism of mouse bone cells in culture and on in vitro calcium
release from fetal limb bones. The effect is dose dependent and
biphasic. Al exerts an inhibiting action at concentrations above
10-6 M, whereas below this concentration, the majority of
cellular activities tested are stimulated. This biphasic dose—
dependent effect appears to be a general phenomenon since a
V
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Fig. 5. Influence of aluminum on ODC activity of osteoblast—like cells.
Symbols represent the cells incubated with: solvent (•); with bPTH
(l0- M) (R); with l,25(OH)2D3 (10-v M) (*); with Al alone (0);
simultaneously with Al and bPTH (s); and with Al plus l,25(OH)2D3
(10 Nt) (A). Values are means SEM ofeight experiments with three
flasks for each point.
similar mode of action has been observed in various in vitro
systems for several other metals [241 and hormones [25—27].
It is difficult to compare the in vitro Al concentrations
employed in serum—free medium, with circulating in vivo Al
concentrations, where Al is largely protein—bound [28]. Fur-
thermore, osteoblast and osteoclast phenotypes were mainly
defined by the digestion procedure used and their cAMP
responses to bPTH and calcitonin [29] in the present study, and
not by morphological criteria. However, some of our data are in
Table 1. Influence ofaluminum, l,25(OH)2D (109M) and bPTH
(109M) on osteoblast proliferation
Treatment of the cells DNA g
Controls 10.10 0.15
Al (10M) 11.98 0.11"
Al (107M) 12.14 0.08"
Al (106M) 13.11 O.09a
Al (3 x l06M) 11.73 0.05"
Al (6 x l06M) 8.13 0.09a
Al (l05M) 7.52 0.1 l
1,25(OH)2D1 (109M) 9.58 0.09
bPTH (109M) 13.01 0.04"
OB cells were plated at a density of 2 x l0 cells/well and cultured for
24 hr with 10 % FCS. The cells were then washed 3 times with BGJ
medium without FCS, incubated in BGJ medium without FCS but
supplemented with 0.1% BSA and/or the test substances for 24 hr.
Values are the means SEM of 24 groups (8 different experiments with 3
wells for each point). Significantly different: a P < 0.001, b p < 0.05.
Treatment cAMP p,nole/g DNA
bPTH 295
Al (108M) + bPTH 87 3"
Al (107M) + bPTH 88 3
Al (106M) ÷ bPTH 89 4"
Al (3 x l0M) + bPTH 62 1"
Al (l05M) + bPTH 43 I"
agreement with several clinical and experimental observations
and may help to clarify the mechanisms of the Al effect on bone
turnover.
Indeed it has been shown that in both severely intoxicated
patients and in intoxicated rats the numbers of osteoblasts and
the rates of bone formation are decreased [5, 7, 81. Moreover
treatment with desferroxiamine, which removes Al from bone,
is associated with an increase in matrix synthesis [30, 31]. Our
data indicate that several mechanisms may be involved in these
CDP NCP Collagen synthesis
dpm/pg DNA dpm/j.g DNA per cent
Treatment
Controls
Al 108M
10 M
10-6 M
1.5x10 6M
3x10 6M
6x10 6M
10 5M
bPTH 10 9M
l.25(OH)2D3 10 M
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Fig. 4. Collagen synthesis by osteoblast—like
cells. Influence of aluminum, bPTH or
I ,25(OH)2D3. Values are means SEM of20
groups (five different experiments with four
wells for each point). Values significantly
different from their corresponding controls,
**D < 0.001; 9P <0.05. The percentage of
collagen synthesis was calculated from CDP
x I00/CDP + 5.4NCP.5 10 15
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Table 2. Interaction between aluminum and bPTH on cellular cAMP
content of osteoblast—like cells
Cells were preincubated with Al or solvent for 2 hr before the
addition of bPTH (l09M) (5 mm). Values are the means SEM of 4
experiments in which each point represent 4 wells. When compared to
addition of bPTH in the absence of Al: "P < 0.001.
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hydrolyses pyrophosphates, which are inhibitors of mineral
deposition [33].
Our data show that at low concentrations (10-8 to 106 M)Al
increases calcium and f3-glucuronidase release from long bones,
and tartrate—resistant acid phosphatase from osteoclast—like
cells. The effect on calcium release disappears at higher con-
centrations (6 x 10_6 M to iO M) and the intracellular activity
of both lysosomal enzymes is inhibited, whereas their release
into the medium persists. These results are in agreement with in
vivo data obtained by Goodman, Gilligan and Horst showing
increased endosteal tibial resorption in Al-intoxicated rats [8].
The rapid hypercalcemia observed in dogs [34] and rats [35]
following a single i.v. injection of Al could also reflect a direct
action of Al on skeletal calcium mobilization. Moreover, Henry
and Norman recently reported that Al administration elevates
serum calcium in vitamin D deficient chicks [36]. All these
observations suggest that the spontaneous hypercalcemia ob-
served in Al-intoxicated patients [37] may be due not only to
reduced calcium entry into the bone, but also to increased
calcium release from the bone.
The relationship between Al and parathryoid gland function
have been extensively analyzed over the past few years, leading
to the conclusion that Al could inhibit PTH release [10—121, thus
inducing the relative PTH deficiency observed in severely
Al-intoxicated patients. Our results show that Al also interferes
with the effect of PTH on bone tissue, not only by derepres sing
the PTH-mediated stimulation of cell proliferation mentioned
above, but also by inhibiting the stimulating effect of bPTH on
cAMP content of osteoblast—like cells, while the basal cAMP
production is unaffected. These results are in agreement with
those reported for perfused tibiae of Al-intoxicated dogs [38].
As in our experiment, Al inhibited the bPTH-induced cAMP
release. These effects, which indicate disturbed osteoblast
function, appear to be specific to bone cells, because Al
intoxication does not alter the renal cAMP response to bPTH
[39].
It has been reported that the metabolism of vitamin D is
disturbed in Al-intoxicated animals [36, 39, 40]. The present
data and those obtained in a previous study [13], show that the
action of vitamin Don bone is also disturbed by the presence of
Al. Al inhibits the stimulating effect of I ,25-(OH),D3 on acid
and alkaline phosphatase of bones in organ culture while
altering the 1,25-(OH)2D3-induced changes in ODC activity of
cultured bone cells.
In conclusion, the present data show that Al influences
several cellular functions in bone tissue and its action is dose
dependent. These findings confirm the depressant effect of Al
intoxication on bone matrix formation observed in vivo and
show that this effect is due not only to the inhibition of collagen
synthesis, but also to the inhibition of cell proliferation. More-
over, Al directly influences bone resorption, and interacts at the
cellular level with the effects of PTH and 1 ,25-(OH)2D3.
**2
0
6O—
**
**
114:
a)
Co
a)
a)
a)8)
. (3o
(3
9)
a)Co.-CO
(88)o
Co
40
20
0
60 r
20
0 L.___ i I I I
0 10-8 iO 10 io
Al concentrations, M
Fig. 6. Effect of aluminum on 45Ca and /3-glucuronidase release from
fetal mouse long bones and on bone f3-glururonidase activity. Values
are means SEM for 10 cultures of radius plus ulna incubated 48 hours.
Values significantly different from their corresponding controls, **D <
0.001, 8P <0.05.
phenomena. First, high concentrations of Al depress the activ-
ity of osteoblast—like cells and reduce collagen synthesis. Sec-
ond, an inhibition of cellular proliferation occurs at these high
Al concentrations, that is, DNA synthesis is depressed as is the
cell growth marker, ornithine—decarboxylase activity (ODC). In
addition, Al depresses the bPTH-mediated stimulation of cell
proliferation.
With regard to the observed in vitro stimulating effect of low
Al concentrations, in patients such an effect would hardly be
detected, because the secondary hyperparathyroidism which
occurs in the majority of them also has a stimulatory action on
bone cellular activity [32].
The effect of Al on bone mineralization could not be tested by
the methods used in this study. However, the inhibition of
alkaline phosphatase activity observed with high Al concentra-
tions may indicate a disturbance of the mineralization process,
since it is generally accepted that alkaline phosphatase
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